JP2003012562A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003012562A5 JP2003012562A5 JP2002106400A JP2002106400A JP2003012562A5 JP 2003012562 A5 JP2003012562 A5 JP 2003012562A5 JP 2002106400 A JP2002106400 A JP 2002106400A JP 2002106400 A JP2002106400 A JP 2002106400A JP 2003012562 A5 JP2003012562 A5 JP 2003012562A5
- Authority
- JP
- Japan
- Prior art keywords
- exchange resin
- active ingredient
- ion exchange
- meq
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 10
- 239000004480 active ingredient Substances 0.000 claims 9
- 239000003456 ion exchange resin Substances 0.000 claims 9
- 229920003303 ion-exchange polymer Polymers 0.000 claims 9
- 239000011347 resin Substances 0.000 claims 6
- 229920005989 resin Polymers 0.000 claims 6
- 239000003957 anion exchange resin Substances 0.000 claims 5
- 238000010521 absorption reaction Methods 0.000 claims 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 125000005395 methacrylic acid group Chemical group 0.000 claims 3
- 125000001302 tertiary amino group Chemical group 0.000 claims 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 239000003729 cation exchange resin Substances 0.000 claims 2
- 238000004132 cross linking Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 229920001268 Cholestyramine Polymers 0.000 claims 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 claims 1
- 125000002843 carboxylic acid group Chemical group 0.000 claims 1
- 229940023913 cation exchange resins Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 229960002296 paroxetine Drugs 0.000 claims 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 1
- 150000003335 secondary amines Chemical class 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28244301P | 2001-04-09 | 2001-04-09 | |
| US60/282443 | 2001-04-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003012562A JP2003012562A (ja) | 2003-01-15 |
| JP2003012562A5 true JP2003012562A5 (enExample) | 2005-09-15 |
| JP4295951B2 JP4295951B2 (ja) | 2009-07-15 |
Family
ID=23081541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002106400A Expired - Lifetime JP4295951B2 (ja) | 2001-04-09 | 2002-04-09 | 活性成分の制御型溶解 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7153497B2 (enExample) |
| EP (1) | EP1250937B1 (enExample) |
| JP (1) | JP4295951B2 (enExample) |
| KR (1) | KR100905453B1 (enExample) |
| DE (1) | DE60232290D1 (enExample) |
| TW (1) | TWI242446B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| WO2006101536A1 (en) * | 2004-11-04 | 2006-09-28 | Akina, Inc. | Fast-melting tablets having taste-masking and sustained release properties |
| EP2018160B1 (en) | 2006-03-16 | 2011-12-14 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8187636B2 (en) | 2006-09-25 | 2012-05-29 | Atlantic Pharmaceuticals, Inc. | Dosage forms for tamper prone therapeutic agents |
| CA2689101C (en) * | 2007-05-30 | 2013-01-22 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
| FR2947276B1 (fr) * | 2009-06-24 | 2012-10-26 | Seppic Sa | Composition cosmetique a base de resines echangeuses d'ions chargees avec des lipoaminoacides |
| US8623409B1 (en) | 2010-10-20 | 2014-01-07 | Tris Pharma Inc. | Clonidine formulation |
| EP2725072B1 (en) | 2012-10-25 | 2015-07-22 | Rohm and Haas Company | Aldehyde abatement with porous amine functional resins |
| US8999393B1 (en) | 2013-01-09 | 2015-04-07 | Edgemont Pharmaceuticals Llc | Sustained release formulations of lorazepam |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| US11505716B2 (en) | 2017-07-11 | 2022-11-22 | Dow Global Technologies Llc | Aqueous dispersion and aqueous coating composition comprising the same |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US11918689B1 (en) | 2020-07-28 | 2024-03-05 | Tris Pharma Inc | Liquid clonidine extended release composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1585174A (en) * | 1976-06-16 | 1981-02-25 | Ici Ltd | Separation of sugars from mixtures |
| CH655507B (enExample) * | 1983-01-12 | 1986-04-30 | ||
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
| GB9005498D0 (en) * | 1990-03-12 | 1990-05-09 | Beecham Group Plc | Composition |
| US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
| GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
-
2002
- 2002-03-22 EP EP02252070A patent/EP1250937B1/en not_active Expired - Lifetime
- 2002-03-22 DE DE60232290T patent/DE60232290D1/de not_active Expired - Lifetime
- 2002-03-26 US US10/107,898 patent/US7153497B2/en not_active Expired - Lifetime
- 2002-03-27 TW TW091106011A patent/TWI242446B/zh not_active IP Right Cessation
- 2002-04-04 KR KR1020020018458A patent/KR100905453B1/ko not_active Expired - Lifetime
- 2002-04-09 JP JP2002106400A patent/JP4295951B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003012562A5 (enExample) | ||
| Srikanth et al. | Ion-exchange resins as controlled drug delivery carriers | |
| TWI381001B (zh) | 吸放濕性超微粒子及使用該超微粒子之製品 | |
| JP2007531758A5 (enExample) | ||
| CN101616738B (zh) | 具有较大孔径的大孔聚合物 | |
| US6534554B1 (en) | Multicomponent ion exchange resins | |
| BRPI0722105A2 (pt) | Géis de polímero ligados por argila | |
| Vijay et al. | Ion exchange resins and their applications | |
| JP2004531609A5 (enExample) | ||
| CN104707580A (zh) | 一种重金属萃取剂微胶囊的制备方法及其在重金属废水处理中的应用 | |
| JP2003012500A5 (enExample) | ||
| RU2008121850A (ru) | Композиции и способы для уничтожения клеток | |
| JP4295951B2 (ja) | 活性成分の制御型溶解 | |
| KR940702731A (ko) | 방출 및 흡착 조절에 유용한 이온 비이드 | |
| Gaur et al. | Ion exchange resins in gastroretentive drug delivery: characteristics, selection, formulation and applications | |
| CN107849179A (zh) | 新颖的铝掺杂的、含亚氨基乙酸基团的螯合树脂 | |
| CN117123195A (zh) | 一种改性聚合物微球及其制备方法和应用 | |
| JP3214632B2 (ja) | 血液浄化用吸着体 | |
| JP3246681B2 (ja) | トランスサイレチン吸着剤 | |
| JP2004518016A5 (enExample) | ||
| KR20020079474A (ko) | 활성성분의 방출 연장 | |
| EP1894629A2 (en) | Method and composition for eliminating odors in ion exchange resins | |
| JP2005525213A (ja) | フィルターを含む消耗品容器 | |
| JP2016123905A (ja) | アニオン交換樹脂及びそれを用いた復水脱塩方法除去方法 | |
| Muzammil et al. | Ion Exchange Resins for Clinical Applications |